231: Clinical Outcome after Multicenter, Open-Label Phase II Trial on Post-Surgery Chemoradiation in Combination with Cetuximab in Squamous Cell Carcinoma of the Head and Neck with High-Risk of Locoregional Recurrence
Titel:
231: Clinical Outcome after Multicenter, Open-Label Phase II Trial on Post-Surgery Chemoradiation in Combination with Cetuximab in Squamous Cell Carcinoma of the Head and Neck with High-Risk of Locoregional Recurrence
Auteur:
Boelke, Edwin Matuschek, Christiane Schipper, Joerg Budach, Volker Belka, Claus Debus, Juergen Wendt, Thomas Stuschke, Martin Wenz, Frederick Henke, Michael Budach, Wilfried